WJ
Wang Julia Aijun
首席财务官
OtherF
内部人交易记录
首席财务官尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Wang Julia Aijun, 首席财务官. Insider active across 2 companies, notably BeiGene, Ltd.. In total, 18 filings have been published. Split: 0 buy · 11 sells. Total volume traded: €777k. Activity tracked since 1 July 2021. The latest transaction was disclosed on 1 July 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Wang Julia Aijun
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
860 股Common StockSEC:0000920148-26-000090:0
893 股Common StockSEC:0000920148-26-000036:0
893 股Common StockSEC:0001127602-25-003711:0
472 股@ US$143.89557.3% 占其流量American Depositary SharesSEC:0001651308-24-000080:0
899 股@ US$155.6615.0% 占其流量American Depositary SharesSEC:0001651308-24-000079:0
154 股@ US$158.23682.6% 占其流量American Depositary SharesSEC:0001651308-24-000074:0
136,240 股0Ordinary SharesSEC:0001651308-24-000056:0
397 股@ US$167.087.0% 占其流量American Depositary SharesSEC:0001651308-24-000016:0
472 股@ US$179.54958.9% 占其流量American Depositary SharesSEC:0001651308-23-000104:0
840 股@ US$182.8516.1% 占其流量American Depositary SharesSEC:0001651308-23-000102:0
107,770 股0Ordinary SharesSEC:0001651308-23-000091:0
343 股@ US$240.20969.0% 占其流量American Depositary SharesSEC:0001651308-23-000037:0
317 股@ US$158.505.5% 占其流量American Depositary SharesSEC:0001651308-22-000125:0
295 股@ US$158.505.1% 占其流量American Depositary SharesSEC:0001651308-22-000119:0
104,377 股0Ordinary SharesSEC:0001651308-22-000112:0
161 股@ US$136.63930.0001% mcap10.3% 占其流量American Depositary SharesSEC:0001651308-22-000084:0
61,750 股0Ordinary SharesSEC:0001651308-22-000035:0
308 股@ US$349.063911.7% 占其流量American Depositary SharesSEC:0001651308-21-000147:0
About Wang Julia Aijun
Wang Julia Aijun is Directeur Financier and has made 18 filings in total. Across the 18 filings in the recent sample, all reported transactions are sales, totaling EUR 777426, over the period from 2021-07-01 to 2026-02-13. The largest filings concern BeiGene, Ltd., including amounts of EUR 140154.5260442326 on 2023-06-27, EUR 130384.7437534823 on 2024-06-26, and EUR 90755.98366096854 on 2021-07-01.